Podcasts about atrial

Heart attacks & strokes are down, but guess what's rising? ⚡ Atrial fibrillation,

Na Fibrilação Atrial (FA) é a arritmia mais comum no consultório do cardiologista – mas será que você está por dentro das últimas mudanças da diretriz europeia?No novo episódio do DozeCast, os cardiologistas Raquel Rios e Mateus Prata recebem dois gigantes da arritmia no Brasil: Dra. Luciana Armaganijan e Dr. Dalmo Moreira. Em 60 minutos, eles destrincham as atualizações práticas da Diretriz da ESC 2024 sobre FA e discutem como essas novas recomendações devem impactar sua conduta no dia a dia.

Join Mark, Henry, and Gary (we are Kate-less unfortunately this week) for discussion of epidural steroid injections for adults with radicular back pain, post a fib ablation management, and oral semaglutide for high-risk patients with Type 2 DM

MAHA report drops—overreach or copout? Western diet during pregnancy tied to autism,ADHD in offspring. Solutions for intractable itching after a burn injury; Mitochondria are morethan mere cellular powerhouses; Atrial fibrillation tied to bacteria lurking in gums; Tips for itchyburning eyes

This week's topics include the worldwide burden of skin cancers, risk of a second stroke when a person is taking anticoagulants, patients supporting each other for weight loss maintenance, and imaging for dense breasts.Program notes:0:45 Dense breast tissue imaging1:40 MRI and contrast enhanced mammography superior2:40 Giving IV contrast with mammography2:53 Burden of skin cancer in older adults worldwide3:52 Greater disease burden in men4:53 More likely to have exam and biopsy5:48 Atrial fibrillation, recurrent stroke risk and anticoagulants6:50 One in six will recur7:50 Atrial appendage occulsion?8:20 Patient delivered weight loss management9:20 Five percent or greater initial weight loss10:20 Reduced the amount of weight regain11:22 Much less than a professional's care12:49 End

Atrial fibrillation remains elusive and deadly. In this episode, Mark Goddard shares his journey from cardiac device management to clinical innovation, highlighting how AI-powered tools are closing diagnostic gaps and enabling predictive care for conditions like atrial fibrillation (AFib). He explains how their wearable, real-time monitoring device empowers providers, improves patient outcomes, and outperforms outdated Holter and patch systems. Tune in and learn how digital health and innovative models can address these challenges and improve patient care! Resources: Connect with and follow Mark Goddard on LinkedIn. Follow InfoBionic.ai on LinkedIn and visit their website!

Be alert to atypical symptoms, such as fatigue or reduced exercise tolerance, particularly in younger patients Serial Holter monitoring and attention to atrial ectopy burden can guide suspicion Wearables like the Apple Watch and Samsung Galaxy Watch are effective adjuncts for rhythm detection Early ablation may be appropriate, even in younger patients with a low CHA₂DS₂-VASc score, if they are symptomatic Collaboration between healthcare professionals and Electrophysiologists is essential to optimise patient outcomes The questions answered in this podcast are listed below.They were compiled by GPs and health professionals around Australia who attended Healthed’s face-to-face seminars. Atrial fibrillation – it's not an uncommon arrhythmia in Australia, is it? What are some of the environmental factors that have been identified as contributing to atrial fibrillation, apart from COVID? Why are we picking up more cases of atrial fibrillation? Are patients becoming more symptomatic? Obstructive sleep apnoea doesn't cause atrial fibrillation, but can it make it permanent? How can the pulmonary veins cause a cardiac arrhythmia? What are the indications for treating patients with ablation? How is it managed? What's the current thinking? How far should a healthcare professionals go in trying to detect atrial fibrillation in patients with unusual symptoms? Host: David Lim | Total Time: 32 mins Expert: Prof Rukshen Weerasooriya, Sub-specialist Cardiac Electrophysiologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

BUFFALO, NY — May 14, 2025 — A new #research paper was #published in Aging (Aging-US) Volume 17, Issue 4, on April 10, 2025, titled “Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation.” In this study, first author Masahiko Takahashi and corresponding author Keisuke Okawa led a research team from Kagawa Prefectural Central Hospital and Hyogo Medical University that investigated whether Factor Xa inhibitors (Xa-Is)—a type of blood thinner—can reduce the risk of heart-related complications in patients over 80 with nonvalvular atrial fibrillation (NVAF). The study found that patients using Xa-Is experienced significantly fewer cardiovascular problems than those on other anticoagulants. This finding is especially relevant, as older adults face a high risk of both stroke and heart disease. Atrial fibrillation is a common heart rhythm disorder, particularly in the elderly, that increases the risk of blood clots, heart failure, and stroke. Anticoagulants are often prescribed to prevent clots, but not all types have the same effects on heart health. This study focused on comparing Xa-Is—specifically rivaroxaban, apixaban, and edoxaban—with commonly used drugs such as warfarin and dabigatran. Researchers followed more than 1,000 patients aged 80 and above for up to five years to assess the long-term impact of these medications on cardiovascular outcomes. Patients who used Xa-Is had significantly lower rates of heart failure, artery disease, and cardiovascular death. The risk of cardiovascular problems in the Xa-I group was less than half that of those on non-Xa-I medications. These benefits remained even after adjusting for factors like age, existing heart conditions, and kidney function. Additionally, stroke and all-cause death rates were notably lower in the Xa-I group. “Xa-Is may be useful for not only anticoagulation but also the prevention of cardiovascular events in very old patients with NVAF.” What makes Xa-Is different, according to the researchers, is their ability to inhibit a specific biological pathway—known as Factor Xa–PAR2—that contributes to inflammation, fibrosis, and damage in blood vessels and heart tissue. This effect extends beyond their traditional role in preventing blood clots. Although the study was conducted at a single medical center in Japan, its rigorous design and long follow-up period enhance the reliability of the findings for real-world clinical decision-making. While further studies, especially across multiple centers, are needed to confirm the full range of benefits, this study strongly suggests that Xa-Is may offer broader cardiovascular protection for very old patients. The findings could influence how clinicians choose blood thinners for elderly individuals with atrial fibrillation, potentially improving both survival and quality of life in this growing population. DOI - https://doi.org/10.18632/aging.206238 Corresponding author - Keisuke Okawa - k-ookawa@chp-kagawa.jp Video short - https://www.youtube.com/watch?v=YtbYpfVDVDI Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206238 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, Factor Xa inhibitor, atrial fibrillation, older patient, cardiovascular events To learn more about the journal, please visit our website at https://www.Aging-US.com​​ and connect with us on social media at: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Bluesky - https://bsky.app/profile/aging-us.bsky.social Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

فیبریلاسیون دهلیزی و تروپونین

Association Between COVID-19 Vaccination and Atrial Arrhythmias in Individuals with Cardiac Implantable Electronic Devices   Guest: Malini Madhavan, M.B.B.S. Host: Anthony H. Kashou, M.D.   In a study of over 7000 individuals with a cardiac implanted device in the Biotronik CERTITUDE registry, the burden of device detected AF was noted to be higher in the 3 months after covid vaccination compared to the 3 months preceding vaccination. A similar trend was observed for Influenza vaccinated individuals. However, when comparing a propensity matched group of controls without COVID vaccination, the trend towards increased burden of AF was similar in the 2 groups. This led the authors to conclude that the observed increase in AF burden represents the natural progression of AF risk rather than vaccine related changes.   Topics Discussed: The study of atrial fibrillation burden after COVID vaccination, including the conclusion. How the incidence of AF after COVID 19 vaccination compares to that after influenza vaccination. Other studies that have investigated arrhythmia occurrence after COVID vaccination. Safety for patients with cardiovascular disease to get vaccinated for COVID 19. References: https://www.heartrhythmjournal.com/article/S1547-5271(22)00914-6/fulltext https://onlinelibrary.wiley.com/doi/epdf/10.1111/jce.16372 https://pmc.ncbi.nlm.nih.gov/articles/PMC9175153/#:~:text=A%20total%20of%202611%20events,COVID%2D19%20vaccine%20doses%20administered Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Updates in Left Atrial Appendage Closure   Guest: Ammar Killu, M.B.B.S. Host: Sharonne Hayes, M.D.   In today's episode of “Interviews With the Experts, listeners will learn how to select patients that may benefit from left atrial appendage occlusion.  Listeners will understand the major differences between currently available commercial devices.    Topics Discussed: What is left atrial appendage closure? Who may benefit from left atrial appendage closure and is there expansion of indications? What devices are currently approved for LAA closure? Are there any newer devices on the horizon? What are the post device anticoagulation/ antithrombotic regimens?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Today, we're diving into the captivating world where cardiology meets cutting-edge technology. Ever wondered how your smartwatch could potentially save your life or how wearable tech is revolutionizing heart rhythm monitoring? You're in for a treat! Joining us is Dr. Yaariv Khaykin, an internationally renowned expert in rhythm disorders. He's a self-proclaimed "heart electrician" with a knack for gadgets and tech, and he's here to guide us through the intersection of traditional cardiology and modern advancements. From exploring the 100-year-old ECG technology to discussing breakthrough wearable devices, this episode is packed with insights that will transform the way you think about heart health. So whether you're a medical professional, a tech enthusiast, or someone just curious about how wearables could benefit your health, stay tuned for a fascinating conversation that proves science fiction is quickly becoming present-day medicine.Episode HighlightsWearables Catch Fleeting Symptoms Wearables effectively detect fleeting health symptoms that traditional monitors might miss, especially heart rhythm abnormalities.ECG's Long-Standing Role ECGs have been crucial in cardiology for over 100 years, providing insight into heart's electrical activity.Technology Elevates Heart Monitoring Advanced tech offers multi-channel monitoring, improving safety and precision in diagnosing heart conditions like arrhythmias.Smartwatches: Medical Utility Evolving Smartwatches like Apple Watch are now FDA-approved for heart monitoring, offering reliable data for clinical decisions.Data in Wearables: Double-Edged Sword While empowering users, wearables can increase anxiety without proper context. Interpretation is key.Improving Life Through Wearables Devices encourage healthy behaviors, tracking sleep, steps, and exercise to guide lifestyle choices for longevity.Heart Rate Variability's Importance High heart rate variability indicates fitness and longevity, while low variability can signal health issues.Non-Invasive Monitoring Innovations Textile-based ECGs provide comfort, easy use, and continuous heart monitoring without traditional discomforts.Bridging Clinical and Consumer Tech The integration of wearables in daily life advances proactive healthcare, offering diagnostic-level insights easily accessible to all.Episode Timestamps00:00 - Ditch the Lab Coat Podcast06:09 - AI enhances ECG interpretation07:03 - Advanced cardiac mapping vest10:30 - Wearables revolutionize heart monitoring14:39 - Wearables' role in health monitoring18:58 - Assessing Apple Watch for heart rhythms21:00 - Atrial fibrillation detection limitations23:49 - Wearable limitations in symptom detection28:41 - Wearable ECG tech achieves 99.9% accuracy29:46 - Medical device risk and standards34:38 - "Tech bros & longevity obsession"38:17 - Wearables: balancing peace and anxiety42:32 - Heart rate variability explained46:02 - Heart tech: ECGs and innovation47:20 - Future of wearable cardiac technologyDISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. 

Dr. Ryan L. Cooley is a board-certified cardiac electrophysiologist with over 20 years of experience treating heart rhythm disorders. After adopting a low-carb lifestyle himself, he reversed his pre-diabetes—an experience that reshaped his approach to patient care. Now, he's a dedicated advocate for low-carb and ketogenic diets, often pairing them with intermittent fasting to help patients take control of their cardiometabolic health. Driven by both science and personal success, Dr. Cooley empowers others to make lasting, life-changing dietary choices. In this episode, Drs. Tro, Brian, and Ryan talk about… (00:00) Intro (02:39) Dr. Ryan's recent experience of being diagnosed with and fighting prostate cancer with natural metabolic therapies (11:34) Dr. Ryan's heart attack experience and what he learned from this experience (16:48) Gene mutations that make people more susceptible to obesity (23:19) Dr. Ryan's revelations about the medical system and nutrition following his heart attack (30:00) Vitamin C and cancer (31:50) Molecular Hydrogen Treatment (35:15) How exercise may have contributed to Dr. Ryan's cardiovascular troubles (37:05) LDL and cardiac events (39:29) Atrial fibrillation and insulin resistance (42:57) Treating atrial fibrillation (48:05) How Dr. Ryan's colleagues have responded to his holistic approach to chronic disease (50:10) Increased AF diagnoses in younger people in recent years (53:39) How Dr. Ryan changed his diet following his cancer diagnosis (57:43) Thermogenic stress (59:13) Stress and metabolic health (01:03:02) Hydrogenated water and why hydrogen is the best antioxidant (01:06:45) Protein and mTOR (01:08:40) All of the supplements Dr. Ryan takes for their cancer fighting benefits and/or their cardiovascular benefits (01:12:24) How Dr. Ryan's near death experiences have changed his outlook on life For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Dr. Ryan L. Cooley: Podcast: https://www.youtube.com/@TheMetabochondriacs Inter Mountain Health: https://doctors.intermountainhealth.org/provider/ryan-l-cooley/2556896 Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

Andrea Scotti, MD, JACC: Case Reports Deputy Editor, is joined by authors Richard Carrick, MD, PhD and Drew Bidmead, BS discussing this study from Carrick et al presented at ACC.25 and published in JACC: Case Reports. Left atrial dissection is a rare, but potentially serious, complication that most commonly arises following mitral valve surgeries. In this report, we describe an unusual case of left atrial dissection that occurred after multi-valve surgical replacement in a patient with hypertrophic cardiomyopathy. While permanent pacemaker placement was required due to recurrent episodes of complete heart block, the patient was otherwise managed safely using a conservative approach without surgical re-intervention.

Andrea Scotti, MD, JACC: Case Reports Deputy Editor, is joined by authors Richard Carrick, MD, PhD and Drew Bidmead, BS discussing this study from Carrick et al presented at ACC.25 and published in JACC: Case Reports. Left atrial dissection is a rare, but potentially serious, complication that most commonly arises following mitral valve surgeries. In this report, we describe an unusual case of left atrial dissection that occurred after multi-valve surgical replacement in a patient with hypertrophic cardiomyopathy. While permanent pacemaker placement was required due to recurrent episodes of complete heart block, the patient was otherwise managed safely using a conservative approach without surgical re-intervention.

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

Commentary by Dr.  Jian'an Wang

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Outcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair: The WATCH-TEER Study

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Safety and Feasibility of 3D Intracardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With WATCHMAN FLX

Post-Cardiac Ablation Atrial Arrhythmia Monitoring   Guest: Suraj Kapa, M.D. Host: Anthony H. Kashou, M.D.   In this episode of the segment "ECG Making Waves," the listener will learn to identify the right monitoring approach for a given patient's arrhythmia considerations around ablation. They will also learn how to list specific considerations when reviewing and interpreting post-ablation arrhythmia ECGs.   Topics Discussed: What specific aspects of the ECG and ECG monitoring are important to look for after cardiac ablation? How do you approach rhythm monitoring discussions with your patients after ablation? What are potential benefits and pitfalls of different monitoring approaches for atrial arrhythmias after ablation?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

This episode covers: Cardiology This Week: A concise summary of recent studies Atrial fibrillation in athletes 'Work and life' of a medical journalist Mythbusters: Female doctors with better outcomes Host: Perry Elliott Guests: Carlos Aguiar, Isabelle van Gelder, Shelley Wood Want to watch that episode? Go to: https://esc365.escardio.org/event/1799   Disclaimer ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests  Stephan Achenbach, Nicolle Kraenkel, Isabelle van Gelder and Shelley Wood have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Our guest today is Evelyn Gamble.  Evelyn is a dedicated healthcare worker and passionate heart disease advocate. With a deep commitment to improving health outcomes, Evelyn uses her personal and professional experiences to raise awareness about heart health, particularly for young adults. As a strong voice for change, she aims to inspire others to take proactive steps in managing their heart health and to advocate for better care and resources for those affected by heart disease.     Definition: A heart arrhythmia, also known as a cardiac arrhythmia, is an abnormal rhythm of the heart. It occurs when the electrical impulses that control the heart's contractions do not function properly.    Causes:    Heart arrhythmias can be caused by a wide range of factors, including:    Heart disease (e.g., coronary artery disease, heart failure) Electrolyte imbalances (e.g., low potassium or magnesium) Certain medications (e.g., stimulants, caffeine) Thyroid disorders Damage to the Vagus Nerve Stress Genetics    Types:    There are many different types of heart arrhythmias, which can be classified based on the rate and rhythm of the heart:    Tachycardia: A rapid heart rate (over 100 beats per minute)    Bradycardia: A slow heart rate (under 60 beats per minute)    Atrial fibrillation: A quivering or irregular rhythm of the upper chambers of the heart (atria)    Ventricular fibrillation: A life-threatening rhythm where the lower chambers of the heart (ventricles) contract irregularly and chaotically    Premature beats: Extra heartbeats that occur early in the rhythm    Symptoms:    Some people with heart arrhythmias may not experience any symptoms. Others may have symptoms such as:    Palpitations (feeling like the heart is racing or fluttering), Chest pain or discomfort, Dizziness or lightheadedness, Fainting, and Shortness of breath.    Diagnosis and Treatment:    To diagnose a heart arrhythmia, your doctor will likely perform a physical exam, ask about your medical history, and take an electrocardiogram (ECG). Treatment options depend on the type and severity of the arrhythmia and may include:    Medications (e.g., beta-blockers, antiarrhythmics) Lifestyle changes (e.g., exercise, stress management) Surgery (e.g., ablation procedure) Implantable devices (e.g., pacemakers, defibrillators)    Outlook: The outlook for people with heart arrhythmias varies depending on the underlying cause and severity of the condition.

LATE BREAKING CLINICAL SCIENCE: AltaValve Atrial Fixation TMVR Early Feasibility Study Results

Atrial fibrillation happens when the heart beats at a very fast rate—typically more than 100 beats per minute. Commonly called AFib, atrial fibrillation is the most common form of arrhythmia, or irregular heartbeat. AFib causes various symptoms and can be very serious. New technology can treat Afib using faster, more effective methods than in the past. In this video, San Diego Health host Susan Taylor talks with Doug Gibson, MD, a Scripps cardiac electrophysiologist and director of cardiac electrophysiology at the Scripps Prebys Cardiovascular Institute.

This episode covers questions on atrial septal defects.Written notes can be found at https://zerotofinals.com/paediatrics/cardiology/asd/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

This episode covers atrial septal defects.Written notes can be found at https://zerotofinals.com/paediatrics/cardiology/asd/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

Emile Daoud, MD, Deputy Editor of JACC: Clinical Electrophysiology discusses a recently published new research artle on the clinical and electrophysiological characteristics of Marshall bundle-related atrial tachycardia

This week we will discuss possible treatment methods for AFIB.   Atrial fibrillation (AFib) is a common type of irregular heart rhythm (arrhythmia) that occurs when the upper chambers of the heart (atria) beat chaotically and out of sync with the lower chambers (ventricles). This can lead to a variety of symptoms, including: Palpitations (a feeling of a racing or irregular heartbeat) Fatigue Shortness of breath Dizziness or lightheadedness Chest discomfort ​ AFib can increase the risk of blood clots, stroke, heart failure, and other heart-related complications. ​ Treatment Options for AFib Management of AFib focuses on controlling the heart rate and rhythm, preventing blood clots, and addressing underlying conditions contributing to the arrhythmia. The choice of treatment depends on the individual's symptoms, overall health, and risk factors. 1. Medications Medications are often the first line of treatment for AFib. These include: Rate-Control Medications Aim to slow the heart rate to a normal range. Common drugs: Beta-blockers (e.g., metoprolol), calcium channel blockers (e.g., diltiazem, verapamil), and digoxin. Rhythm-Control Medications Help restore and maintain a normal heart rhythm. Common drugs: Antiarrhythmics like amiodarone, flecainide, or sotalol. Anticoagulants (Blood Thinners) Reduce the risk of stroke by preventing blood clots. Examples: Warfarin, direct oral anticoagulants (DOACs) like apixaban (Eliquis) or rivaroxaban (Xarelto). 2. Ablation Therapy Ablation is a minimally invasive procedure aimed at correcting the electrical signals causing AFib. It is typically recommended for individuals who: Do not respond to or cannot tolerate medications. Have recurrent or persistent AFib that significantly impacts quality of life. Types of ablation: Catheter Ablation Uses thin tubes (catheters) inserted into blood vessels to deliver energy (radiofrequency or cryotherapy) to destroy small areas of heart tissue causing abnormal electrical signals. Surgical Ablation (Maze Procedure) Often performed during open-heart surgery for other conditions, creating scar tissue to block abnormal signals. Both options have high success rates, but catheter ablation is more commonly performed due to its minimally invasive nature. Choosing the Right Treatment Deciding between medications or ablation depends on factors such as: The severity and frequency of symptoms. The presence of other medical conditions. Patient preference and lifestyle. Consultation with a cardiologist or electrophysiologist is crucial to tailor treatment to the individual's needs.

Controle de ritmo ou frequência cardíaca na Fibrilação Atrial? by Cardiopapers

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on flow dynamic factors correlated with device-related thrombosis after left atrial appendage occlusion.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another episode of "Ditch the Lab Coat," where we break down complex medical science in an engaging and relatable way. In today's episode, our hosts, Dr. Mark Bonta and Dr. Zachary Laksman, dive deep into the nuances of managing atrial fibrillation (AFib). We'll dissect the foundation and challenges of current treatment guidelines, explore the growing role of atrial fibrillation ablation, and discuss the fascinating phenomenon of "Holiday Heart."Dr. Laksman will also share insights from his cutting-edge work at the intersection of genetics and personalized medicine, including the innovative MyTrials AI platform he's co-founded. This tool aims to democratize access to clinical trials using artificial intelligence, making them accessible irrespective of personal networks. We'll cover the emerging potential of wearables in heart rhythm monitoring, the importance of lifestyle interventions, and the evolving landscape of AFib treatment.Whether you're a medical professional or simply curious about heart health, this episode offers valuable perspectives and practical advice. Stay tuned as we unravel these topics and more with the expertise of Dr. Zachary Laksman, an acclaimed heart rhythm specialist and leader in cardiogenetics. Don't forget to check out our new website and engage with us for more insightful content. Let's get started!00:00 - Seek professional advice, not podcast opinions.05:50 - Wearable devices: Reliable, clinically relevant, widely used.08:50 - Heart doctor: Electrician managing heart's nerve impulses.12:50 - Atrial fibrillation increases stroke risk despite rhythm.14:19 - Smartwatch inconsistencies in detecting atrial fibrillation.19:33 - Rhythm control improves life quality and longevity.20:17 - Modifiable and unmodifiable risk factors affect atrial fibrillation.25:56 - Researching interventions for high-risk patient outcomes.28:24 - Lifestyle changes reduce recurrent atrial fibrillation likelihood.31:10 - Shock hearts carefully; consider anticoagulants beforehand.33:52 - Are guidelines fear-mongering or evidence-based?37:55 - Electrophysiology advances improve atrial fibrillation ablation.41:54 - Tailoring medicine to individuals for better outcomes.46:02 - AI aids connection, education, breaking trial barriers.48:43 - Helping people navigate medical concerns and care.53:44 - Heart rhythms, paddles, blood thinners, stroke prevention.55:27 - Zach's AI project expands clinical trial access.

Kaue Malpighi e Lucca Cirillo convidam Rafael Martins (@ecg_aulas) para conversar sobre manejo de fibrilação atrial no PS.Referências em breve.

JACC Deputy Editor Erica S. Spatz, MD, FACC, joins author Rishi Wadhera, MD, to discuss his paper on rural and urban differences in cardiovascular mortality in the United States, and the impact of the COVID-19 pandemic.

In this episode, we discuss recent findings on the potential risks of left atrial appendage closure (LAAC) in cardiac surgery patients without prior atrial fibrillation. The study highlights an increased risk of new-onset postoperative AF and prolonged hospital stays without clear benefits in mortality or stroke prevention. The Vasopressor & Inotrope HandbookAmazon: ⁠⁠https://amzn.to/3UvFFVf⁠⁠ (affiliate link) Signed Copy: ⁠⁠https://eddyjoemd.myshopify.com/products/the-vasopressor-inotrope-handbook⁠ Movember Link: ⁠https://movember.com/m/eddyjoemd?mc=1⁠ Citation: Shuhaiber JH, Abbas M, Morland T, Kirchner HL, El-Manzalawy Y. Atrial appendage closure is associated with increased risk for postoperative atrial fibrillation. J Cardiothorac Surg. 2024 Nov 2;19(1):619. doi: 10.1186/s13019-024-03119-6. PMID: 39488696. --- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Amit N. Vora, MD, MPH, FACC, discuss a recently published original research paper reporting the association of physician certification and outcomes among patients undergoing left atrial appendage occlusion.

Taquicardia atrial não sustentada by Cardiopapers

In this episode, Jian'an Wang discusses a pivotal study on the long-term outcomes of left atrial appendage occlusion (LAAO) for stroke prevention in patients with non-valvular atrial fibrillation, analyzing data from over 3,000 patients across China. The findings reveal that combining LAAO with ablation significantly reduces ischemic events, highlighting the importance of tailored procedural strategies and anticoagulation regimens to enhance patient care.

In this episode, Professor Yong-Joon Lee discusses a significant study on the one-year clinical outcomes of left atrial appendage occlusion (LAAO) using the Watchman device in older patients with non-valvular atrial fibrillation. The findings highlight the procedure's safety and efficacy, revealing that combined LAAO and ablation significantly reduce the risk of thromboembolic events, while also addressing gaps between clinical guidelines and real-world practices.

Atrial fibrillation, or A fib for short, is the most common heart rhythm issue that plagues people. About 30% of people will experience this rhythm disorder at some time in their lives, an issue that becomes more and more likely as we age. The rhythm is typically experienced as the sudden onset of breathlessness and lightheadedness, and sometimes chest pain, even while you are sitting or relaxing. This is because, with A fib, the heart rate is typically in the range of 150-220 beats per minute, way above the normal resting heart rate of 60-70 beats per minute. It's the result of chaotic electrical signals originating from the atria of the heart, the normally thin-walled sacks at the top of the heart on the right and left side, i.e., the right and left atria. Beyond the symptoms of breathlessness and lightheadedness, A fib puts you at risk for stroke—not mini-strokes, but large catastrophic strokes. This is because there is a passive sack or appendage attached to the side of the left atrium called the left atrial appendage. Because during a bout of A fib, the atria stop their normal contractions in synchrony with the powerful ventricles, the main pumping chambers of the heart, blood stasis or standstill occurs, allowing the formation of blood clots in the left atrial appendage. Should the blood clot fragment or dislodge, it can go to your brain, resulting in a catastrophic stroke. This is why, in conventional cardiac care, blood thinners are administered almost immediately with the onset of A. fib. The management of this abnormal heart rhythm is fraught with difficulties and complications: toxic pharmaceuticals, procedures such as DC cardioversion in which a large and painful electrical shock is delivered with paddles to your chest, and others. So it is a good idea to take steps to avoid ever having this abnormal heart rhythm. Conventional advice typically includes achieving such things as controlling blood sugar and blood pressure with prescription drugs, or losing excess weight. But this leaves out some hugely important strategies that you can readily adopt that reduce your potential for experiencing A fib, as well as numerous other health problems. So that is the topic we consider here in this episode of the Defiant Health podcast.________________________________________________________________________________For BiotiQuest probiotics including Sugar Shift, go here.A 15% discount is available for Defiant Health podcast listeners by entering discount code UNDOC15 (case-sensitive) at checkout.*_________________________________________________________________________________Get your 15% Paleovalley discount on fermented grass-fed beef sticks, Bone Broth Collagen, low-carb snack bars and other high-quality organic foods here.* For 12% off every order of grass-fed and pasture-raised meats from Wild Pastures, go Support the showBooks: Super Gut: The 4-Week Plan to Reprogram Your Microbiome, Restore Health, and Lose Weight Wheat Belly: Lose the Wheat, Lose the Weight and Find Your Path Back to Health; revised & expanded ed

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on automated assessment of right atrial pressure from ultrasound videos using machine learning.

Atrial fibrillation can be a tricky thing to manage in the ED. Sometimes it is not always clear if you should treat it, how you should treat it, or if it's even safe to treat. In this episode, Ray Isenburg and host Will Smith discuss the basics of AFib, how to treat it (both chemically and/or electrically), when is it safe to treat, and how to determine if this is something worth treating or if there is other pathology occurring that, once resolved, will resolve the heart rhythm.

In the September 3, 2024, issue of JACC, Dr. Samuel Reinhart and team find that using direct oral anticoagulants alone is associated with fewer adverse events compared to combining them with aspirin after left atrial appendage occlusion. Their large-scale study suggests this streamlined approach might be optimal, though further randomized trials are needed to address limitations and refine long-term antithrombotic strategies.

Penditure Exclusion System: Left Atrial Appendage ManagementHost: Pieter KappeteinGuests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of MichiganDr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia Segment 1: Candidates, Circumstances, Clip Placement

Penditure Exclusion System: Left Atrial Appendage ManagementHost: Pieter KappeteinGuests:Dr. Robert Hawkins – Frankel Cardiovascular Center, University of MichiganDr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia Segment 2: Robotic Closure, Appendage management for all AFib patients

HRS24: LAA Occlusion

Welcome to the HealthspanMD Podcast with Dr. Robert Todd Hurst, MD, FACC, FASE. In this episode, we dive deep into the science of longevity and explore the critical issues surrounding heart rhythm problems.   Featuring the highly respected electrophysiologist, Dr. Divyashree Varma, this episode is packed with valuable insights and practical advice for anyone interested in heart health.  Timestamps:  00:01:27 - Introduction by Lisa Hurst: Revolutionizing primary care with HealthSpanMD.  02:25 - Welcome to the HealthspanMD Podcast: Discussing heart rhythm issues and their impact on longevity.  04:44 - Dr. Hurst's ER story: The importance of verifying diagnoses.  06:57 - Introduction of Dr. Divyashree Varma: Understanding the role of an electrophysiologist.  09:08 - Common heart rhythm problems: From atrial fibrillation to ventricular arrhythmias.  11:22 - Warning signs of serious heart conditions: What to watch out for.  13:43 - The rise of consumer rhythm monitoring devices: Benefits and limitations.  16:01 - The challenge of diagnosing intermittent symptoms: Strategies and tools.  18:15 - Atrial fibrillation epidemic: Statistics, risks, and the role of technology.  20:36 - Improving AFib care: The need for early referral to electrophysiologists.  22:53 - Evolution of AFib management: From medication to modern ablation techniques.  25:15 - Contemporary AFib care: The importance of early diagnosis and treatment.  27:38 - Innovations in AFib ablation: Safety, efficacy, and patient outcomes.  29:59 - Different ablation strategies: Radiofrequency, cryoablation, and pulse field ablation.  32:18 - Four pillars of AFib treatment: Stroke prophylaxis, rate control, rhythm control, and risk factor modification.  34:37 - Risk factor modification: A whole-person approach to managing AFib.  36:56 - Effective risk factor management: Case studies and outcomes.  39:19 - Quality of life impacts of AFib: Strategies to help patients live well.  41:37 - Advice for aspiring electrophysiologists: Empowering the next generation of doctors.  44:00 - Conclusion and call to action: Educate yourself, seek second opinions, and be proactive in your health care.  Tune in for an enlightening conversation on how to take charge of your heart health and improve your longevity with expert insights from Dr. Robert Todd Hurst, MD, FACC, FASE and Dr. Divyashree Varma.   For more information and to schedule an appointment, visit HealthspanMD.com or call 480-847-2575.  Learn more about HealthspanMD at HealthSpanMD.com   Connect with us on LinkedIn, Facebook, Instagram, and YouTube  This show is produced by Mathew Blades and Sam Robertson. 

On this episode of our award-winning podcast, a leading expert in electrophysiology explains the pathophysiology of atrial fibrillation and how therapies for it have evolved over the years, with pulsed field ablation emerging as the newest approach.   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal Clinical Operations and Quality Vizient Guest: Thomas Munger, MD Chair, Heart Rhythm Division Associate Professor of Medicine Mayo Clinic   Show Notes: [00:50] Atrial fibrillation: pathophysiology and risk factors [03:20] Treating rhythm and treating rate [07:01] Efficacy of ablation and other treatments [09:40] Pulse field ablation   Links | Resources: To contact Modern Practice: modernpracticepodcast@vizientinc.com Dr. Munger's email: munger.thomas@mayo.edu More information (Vizient): Additional pulsed field ablation resources Information on improving an electrophysiology program (Vizient): Optimizing your EP program     Subscribe Today! Apple Podcasts Amazon Podcasts Android Spotify RSS Feed        

Can you please discuss the xylitol and cardiovascular risk study? Do I have to stop using xylitol spray, mouthwash and gum now? What about DGL?; I've been diagnosed with Atrial fibrillation. What do you think of Pulsed Field Ablation?; I have Hypertrophic Obstructive Cardiomyopathy. What would you recommend?; I'm 5' 2" and 185 lbs. Would I benefit from Calocurb?

Atrial fibrillation (1:30), sFlt-1/PlGF ratio in preeclampsia (4:50), hyaluronic acid for wounds (6:40), substance misuse (9:00), nirsevimab (12:50), and AFP Clinical Answers (14:10).

This week we review a report from Italy regarding the observation of RA disk thrombus formation in some patients following GORE Cardioform ASD closure. How common is this complication seen and are there some patient or device characteristics that would be considered higher risk for this complication? How does this information square with the Assured trial data? Why might there be differences between the two data sources? We speak with Associate Professor of Pediatrics at Kravis Children's Hospital at Mount Sinai, Dr. Barry Love who is also Director of the Congenital Cardiac Catheterization Laboratory at Mount Sinai Hospital.  https://doi.org/10.1002/ccd.31002